Professor Gerard Evan FMedSci FRS
Gerard Evan is an eminent biologist whose main research focus is to determine the molecular basis of cancer. Gerard has made crucial contributions to our understanding of the mechanisms that lead to the formation of cancer. These developments are important in the development of potential new therapies.
Notably, Gerard identified the protein encoded by the c-Myc gene, which is dysregulated in most cancers. He also discovered that the product of genes such as c-Myc can encourage cell growth as well as cell death, which typically kills potentially cancerous cells.
Gerard is currently Sir William Dunn Professor of Biochemistry at the University of Cambridge. He co-directs a laboratory with Trevor Littlewood, which focuses on developing a suite of technologies that allow any gene to be switched on or off in an adult mouse. He is a Founding Editor of the journal Disease Models and Mechanisms.
Interest and expertise
- Biochemistry and molecular cell biology
- Cell biology (incl molecular cell biology), Molecular immunology
- Organismal biology, evolution and ecology
tumour suppressor, cancer, oncogene, therapy